Cargando…
Sickle cell disease complications: Prevalence and resource utilization
OBJECTIVES: This study evaluated the prevalence rate of vaso-occlusive crisis (VOC) episodes, rates of uncomplicated and complicated VOC episodes, and the primary reasons for emergency room (ER) visits and inpatient admissions for sickle cell disease (SCD) patients. METHODS: The Medicaid Analytic ex...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611562/ https://www.ncbi.nlm.nih.gov/pubmed/31276525 http://dx.doi.org/10.1371/journal.pone.0214355 |
_version_ | 1783432717059227648 |
---|---|
author | Shah, Nirmish Bhor, Menaka Xie, Lin Paulose, Jincy Yuce, Huseyin |
author_facet | Shah, Nirmish Bhor, Menaka Xie, Lin Paulose, Jincy Yuce, Huseyin |
author_sort | Shah, Nirmish |
collection | PubMed |
description | OBJECTIVES: This study evaluated the prevalence rate of vaso-occlusive crisis (VOC) episodes, rates of uncomplicated and complicated VOC episodes, and the primary reasons for emergency room (ER) visits and inpatient admissions for sickle cell disease (SCD) patients. METHODS: The Medicaid Analytic extracts database was used to identify adult SCD patients using claims from 01JUL2009-31DEC2012. The date of the first observed SCD claim was designated as the index date. Patients were required to have continuous medical and pharmacy benefits for ≥6 months baseline and ≥12 months follow-up period. Patient demographics, baseline clinical characteristics, the rate of uncomplicated and complicated VOC (VOC with concomitant SCD complications) episodes, and reasons for ER visits and inpatient stays were analyzed descriptively. RESULTS: A total of 8,521 patients were included in the analysis, with a median age of 30 years. The average follow-up period was 2.7 years. The rate of VOC episodes anytime in the follow-up was 3.31 in person-years. During the first-year follow-up period, an average of 2.79 VOC episodes were identified per SCD patients, with 1.06 VOC episodes treated in inpatient setting and 0.90 VOC episodes in ER without admission. A total of 76,154 VOC episodes were identified during the entire follow-up period for the overall SCD patients. Most of the VOC episodes (70.3% [n = 53,523]) were uncomplicated episodes, and 29.7% were complicated episodes. Using primary diagnosis claims only, the most frequent complications during the VOC episode were infectious diseases (25.9%), fever (21.8%), and pulmonary disorders (16.2%). Among ER and hospitalizations related to VOC or SCD complication, ~85.0% had VOCs as the primary reason for admission; 15.0% had SCD complications as the primary reason. CONCLUSION: In summary, SCD and its related comorbidities and complications result in high acute health care utilization. In addition, VOC remains the primary reason for SCD patients’ ER visits and inpatient admissions. |
format | Online Article Text |
id | pubmed-6611562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-66115622019-07-12 Sickle cell disease complications: Prevalence and resource utilization Shah, Nirmish Bhor, Menaka Xie, Lin Paulose, Jincy Yuce, Huseyin PLoS One Research Article OBJECTIVES: This study evaluated the prevalence rate of vaso-occlusive crisis (VOC) episodes, rates of uncomplicated and complicated VOC episodes, and the primary reasons for emergency room (ER) visits and inpatient admissions for sickle cell disease (SCD) patients. METHODS: The Medicaid Analytic extracts database was used to identify adult SCD patients using claims from 01JUL2009-31DEC2012. The date of the first observed SCD claim was designated as the index date. Patients were required to have continuous medical and pharmacy benefits for ≥6 months baseline and ≥12 months follow-up period. Patient demographics, baseline clinical characteristics, the rate of uncomplicated and complicated VOC (VOC with concomitant SCD complications) episodes, and reasons for ER visits and inpatient stays were analyzed descriptively. RESULTS: A total of 8,521 patients were included in the analysis, with a median age of 30 years. The average follow-up period was 2.7 years. The rate of VOC episodes anytime in the follow-up was 3.31 in person-years. During the first-year follow-up period, an average of 2.79 VOC episodes were identified per SCD patients, with 1.06 VOC episodes treated in inpatient setting and 0.90 VOC episodes in ER without admission. A total of 76,154 VOC episodes were identified during the entire follow-up period for the overall SCD patients. Most of the VOC episodes (70.3% [n = 53,523]) were uncomplicated episodes, and 29.7% were complicated episodes. Using primary diagnosis claims only, the most frequent complications during the VOC episode were infectious diseases (25.9%), fever (21.8%), and pulmonary disorders (16.2%). Among ER and hospitalizations related to VOC or SCD complication, ~85.0% had VOCs as the primary reason for admission; 15.0% had SCD complications as the primary reason. CONCLUSION: In summary, SCD and its related comorbidities and complications result in high acute health care utilization. In addition, VOC remains the primary reason for SCD patients’ ER visits and inpatient admissions. Public Library of Science 2019-07-05 /pmc/articles/PMC6611562/ /pubmed/31276525 http://dx.doi.org/10.1371/journal.pone.0214355 Text en © 2019 Shah et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Shah, Nirmish Bhor, Menaka Xie, Lin Paulose, Jincy Yuce, Huseyin Sickle cell disease complications: Prevalence and resource utilization |
title | Sickle cell disease complications: Prevalence and resource utilization |
title_full | Sickle cell disease complications: Prevalence and resource utilization |
title_fullStr | Sickle cell disease complications: Prevalence and resource utilization |
title_full_unstemmed | Sickle cell disease complications: Prevalence and resource utilization |
title_short | Sickle cell disease complications: Prevalence and resource utilization |
title_sort | sickle cell disease complications: prevalence and resource utilization |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611562/ https://www.ncbi.nlm.nih.gov/pubmed/31276525 http://dx.doi.org/10.1371/journal.pone.0214355 |
work_keys_str_mv | AT shahnirmish sicklecelldiseasecomplicationsprevalenceandresourceutilization AT bhormenaka sicklecelldiseasecomplicationsprevalenceandresourceutilization AT xielin sicklecelldiseasecomplicationsprevalenceandresourceutilization AT paulosejincy sicklecelldiseasecomplicationsprevalenceandresourceutilization AT yucehuseyin sicklecelldiseasecomplicationsprevalenceandresourceutilization |